Superinvestors / Hillman Capital Management
Mark Hillman
Hillman Capital Management
Intrinsic-value driven value
$144.00M 13F value
56 positions · as of 2026-03-31 · filed 2026-05-15
This quarter
6 new6 exited25 added23 trimmed
Positions held steady are not reported as moves, so they are absent from these counts.
Largest positions
By weight · every resolvable issuer links to its company page · tags are this quarter's reported move
| Ticker | Issuer | % of portfolio | Value |
|---|---|---|---|
| BIIB | BIOGEN INCDECREASED -3.2% | 3.76% | $5.42M |
| — | E I DuPontDECREASED -11.5% | 3.75% | $5.40M |
| WBD | WARNER BROS DISCOVERY INCDECREASED -8.5% | 3.74% | $5.39M |
| GSK | GSK PLCDECREASED -14.8% | 3.73% | $5.38M |
| IFF | INTERNATIONAL FLAVORS&FRAGRADECREASED -4.3% | 3.67% | $5.28M |
Showing 5 of 56
Values are as disclosed on this manager’s own 13F for its own quarter. 13F covers US-listed long equity only, so this is not the manager’s entire portfolio.
See all 56 positions
Mark Hillman's full reported portfolio with every weight, and the complete list of what they bought, sold and trimmed last quarter — free with an account, no card required.
Sign in free